Care este prețul pentru DelMar Pharmaceuticals, Inc. (DMPWW)

Prețul pentru DelMar Pharmaceuticals, Inc. (DMPWW) este $0.005

Care este capitalizarea de piață pentru DelMar Pharmaceuticals, Inc. (DMPWW)

Capitalizarea de piață pentru DelMar Pharmaceuticals, Inc. (DMPWW) este $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Splituri de Acțiuni

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

An	Split	Multiplu	Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.

Split

Multiplu

Multiplu cumulativ

Nu sunt suficiente date pentru perioada selectată.

Companie	Număr total de splituri	Multiplu cumulativ	Țara
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
UCB S.A. UCB.BR	0	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR

Companie

Număr total de splituri

Multiplu cumulativ

Țara